Feb. 29, 2020: Issue #1031

TOP STORIES - Diabetes News & Research

Canagliflozin for Those on Triple Drug Therapy with Uncontrolled Diabetes

Glycemic Variability (GV) Increases Risk For Poorer Outcomes

Medication Adherence and its Effect on Diabetes Outcomes

Letter from the Editor
Feb. 29, 2020

Today I had a webinar with our interns on diabetes medications, insulin and adherence. Most of the program was on how to make the patient feel like they were part of the solution and take ownership. Like most new medical professionals, they felt that patients would do what was right without question, and have no reason to question why we have them do things.

We spent considerable time talking about medication choices and why patient buy-in was so important for success. We looked at why certain people do better on certain regimens, and why finding the right combination of meds is about more than just what will work, but we also have to take into account what patients will have to do once they start.

One of our former interns, Jordan Boyd, PharmD. Candidate of Florida Agricultural & Mechanical University School of Pharmacy, recently found a great article on how medication regimens affect adherence; I am sharing this with you as I did the interns.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief

Doctor's Option lab test products include rapid tests and CLIA certified fingerstick lab tests.

Rapid tests offer immediate test results to provide doctors with point of care test results in as little as 90 seconds.

Fingerstick lab tests provide CLIA certified lab accurate results. Each fingerstick lab test collection kit comes with a prepaid postage return envelope and everything you need to obtain and collect your fingerstick blood sample in a 510K FDA approved device.

Fingerstick lab tests are great for people who want to monitor their blood sugar, cholesterol, lipids and other important bio-markers at home or on the go.

Visit Doctor's Option

Newsflash

The only FDA-approved liquid formulation of extended-release metformin from Sun Pharma is now available in the United States.

Fact: Late Bedtimes for Children Increase Risk For Obesity and Diabetes

This study aimed to compare sleep in young children at different obesity risks, which were based on parental weight, as well as to explore the longitudinal associations of sleep characteristics with adiposity. It included 107 children, of which 43 had normal-weight parents (low obesity risk), and 64 had parents with overweight or obesity (high obesity risk). Sleep was measured yearly from ages 2 to 6 years by using actigraphy. The outcome variables, also measured annually, were BMI z score and waist circumference. The researchers were able to objectively measure sleep characteristics via the wrist tracker rather than relying on information relayed by parents and children.

The results showed that there was no difference in sleep patterns among children at different risks. A higher short sleep duration score was associated with a more significant increase in BMI z score across ages. Independently of sleep duration, a higher late sleep score was associated with more substantial increases in BMI z score, and waist circumference. Moreover, compared with children at low risk and without habitual late sleep, children at high risk and with routine late sleep had more significant increases in BMI z score (0.93; 95% CI 0.40 to 1.45) and waist circumference (3.45 cm; 95% CI 1.78 to 5.12). So, from the results, it was concluded that more frequent exposures to late sleep were associated with more significant increases in adiposity measures from ages 2 to 6 years, particularly in children whose parents had obesity.Journal of Pediatrics Feb 2020

Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters:

Antonio Bess, Pharm D Candidate, Florida Agricultural & Mechanical University School of Pharmacy

Jordan Boyd, PharmD. Candidate Florida Agricultural & Mechanical University School of Pharmacy

Alessa Grieff, PharmD Candidate, University of South Florida College of Pharmacy

George McConnell, PharmD. Candidate, LECOM School of Pharmacy

Sandra Zaki, PharmD Candidate, Florida A&M University

About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.

Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com

Diabetes In Control
810 Bear Tavern Rd, Suite 102
Ewing, NJ, 08628, United States

DiabetesInControl.com | Contact Us
Subscription Center | Update Profile
Unsubscribe

Feb. 29, 2020: Issue #1031

TOP STORIES - Diabetes News & Research

Newsflash

TOP STORIES - Diabetes News and Research

Fact: Late Bedtimes for Children Increase Risk For Obesity and Diabetes

Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters: